Albemarle (ALB) Financials

Albemarle’s latest results show a business that is still producing solid operating cash flow, but with earnings and revenue under significant pressure versus the stronger 2022-2023 period. In Q1 2026, the company generated $1.43 billion of revenue and $233.5 million of operating income, but net income attributable to common shareholders was lower at $277.4 million after preferred dividends and noncontrolling interests. The balance sheet remains reasonably liquid, with $1.09 billion in cash, but debt is still sizable and the latest quarter showed a sharp cash outflow from financing activities as Albemarle repaid more than $1.3 billion of debt.

Over the last four years, the biggest trend is a normalization from peak profitability to a much tougher earnings environment. In 2023, Albemarle posted very strong results at times, including Q1 2023 revenue of $2.58 billion and net income of $1.28 billion. But by 2024 and 2025, margins compressed sharply, and several quarters swung to losses. The recent quarters suggest the company is working through a cyclical downturn in pricing and profitability, especially after the very weak Q3 and Q4 2024 results.

• Q1 2026 operating cash flow was healthy at $346.2 million, showing the core business is still generating cash despite softer conditions.
• The company ended Q1 2026 with $1.09 billion in cash and equivalents, giving it a meaningful liquidity cushion.
• Q1 2026 gross profit was $501.0 million, much better than the loss-making quarters seen in late 2024.
• Q1 2026 operating income of $233.5 million marks a clear improvement from the deep operating losses seen in Q3 and Q4 2024.
• Revenue in Q1 2026 rose modestly year over year to $1.43 billion, suggesting some stabilization in the top line.
• Depreciation remains a large non-cash expense, but it also helps support reported cash flow; Q1 2026 depreciation was $157.8 million.
• Total assets were $15.14 billion in Q1 2026, down from $17.15 billion in Q3 2025 and below prior-year highs, reflecting a leaner asset base.
• Inventories remained elevated at $1.35 billion in Q1 2026, which may indicate slower turnover or working-capital needs.
• Goodwill and intangible assets remain material parts of the balance sheet, so investors should keep an eye on future impairment risk if conditions weaken again.
• Q1 2026 capital spending was $98.7 million, a relatively controlled level compared with some prior periods.
• Q1 2026 net cash from financing activities was a large negative $1.41 billion, driven mainly by debt repayment of $1.31 billion.
• Long-term debt was still $1.81 billion in Q1 2026, and total liabilities were $5.03 billion, so leverage remains important.
• The company has been highly cyclical: Q3 2024 and Q4 2024 both showed steep losses, including Q4 2024 net income of negative $401.8 million and Q3 2024 net income of negative $1.06 billion.
• Gross margin has been volatile and at times very weak, with Q4 2024 gross profit only $197.9 million on $1.43 billion of revenue.
• The share count has stayed roughly flat around 118 million shares, so earnings recovery will likely depend more on business improvement than on buybacks.

Bottom line: Albemarle still has a strong cash-generating profile in the current quarter, but the multi-year trend shows a sharp retreat from the exceptional profitability of 2023. The stock’s fundamental story now hinges on whether management can sustain operating cash flow, reduce debt, and restore margins as the lithium market stabilizes.